Article Category: review-article
Publié en ligne: 29 janv. 2021
Pages: 1 - 6
© 2020 Rachel MacKellar., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
j.asam-2020-005.tab.001
| Recurrence | Major bleed |
---|
Rivaroxaban 10mg od | 1.2% | 0.4% |
Rivaroxaban 20mg od | 1.5% | 0.5% |
Aspirin 100mg od | 4.4% | 0.4% |
Apixaban 2.5mg bd | 1.7% | 0.2% |
Apixaban 5mg bd | 1.7% | 0.1% |
Placebo | 8.8% | 0.5% |